News
A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...
With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...
UnitedHealth is trying to calm investor nerves with a memo full of optimism and disclaimers. CEO Stephen Hemsley, freshly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback